Summaries Of Treatment Of Breast Cancer in Our Clinic

OBJECTIVE: in this study, we have evaulate, retrospectively, the treatment of 327 patients who had been diagnosed with Breast Cancer.
STUDY DESIGN: 327 patients who reciev·e: d treatments ( Radiotherapy, systematic chemotheraphy, horomonetheraphy and combined therapies) had been stuided under prognostic factors and /oca/-regional reoccurance but also in distant metastatic occurance periods.
RESULTS: 245 patients recieved adjacent-external­radiotherapy (4600 6000 cGy), 72 patient recieved no radiotheraphy and 10 patients stopped radiotherapy, before comp/etion. 208 patients received adjuvan systematic chemotheraphy (CMF or FFEC), 263 patients received adjuvan hormonotherahpy (Tamoksifen 20 mglday.). 20.1 %of the patient (65 people) received only radiotherahpy, 6.7 % (22 people) only chemothrepahy, 49.5 % (162 people) radiotheraphy+chemotheraphy, 7.3% (24 people) chemotheraphy+hormonotheraphy and 8.2% (28 people) received radio theraphy+hormonotheraphy.
CONCULSION: Distant metastases had been /east observed in patients who received: Surgury+radiotherapy+chemotherapy, patiens receivinð combined treatment methods approximaýely 70% survial rates.

Meme Kanserinde Tedavi Sonuçlarýmýz

AMAÇ: Bu çalýþmada kliniðimizde takip ve tedavileri yapýlan Meme Ca tanýsý almýþ 327 hastanýn tedavi sonuçlarý retrospektif olarak deðerlendirilerek tartýþýlmýþtýr.
MATERYAL VE METOD: 1987-1995 yýllarý arasýnda Þiþli Etfal eðitim ve araþtýrma hastanesi radyasyon onkolojisi kliniðine müracaat eden patolojik olarak Meme Ca tanýsý almýþ 327 hastanýn tedavi ( radyo terapi, sistemik kemoterapi, hormona terapi, kombine tedavi) sonuçlarý prognostik faktörler eþliðinde saðkalým ve /okorejyonel nüks ve uzak metastas oluþ süreleri açýsýndan deðerlendirilmiþtir.
BULGULAR: Hastalarýn 245 tanesine adjuvan externa/ radyoterapi (4600 6000 cGY) uygulanmýþ 72 hastaya radyoterapi yapýlmamýþtýr. Toplam 10 hasta radyoterapi uygulamasýna yarým býrakmýþtýr. 208 hastaya adjuvan sistemlik kemoterapi (CMF veya FEC)uygulanmýþtýr. 263 hastaya adjuvan hormonoterapi 22‘sine j%6.7) tek baþýna kemoterapi, l 62‘sine (%49.5) radyoterapi+kemoterapi, 24‘ iine (%7.3) kemoterapi+hormonoterapi, 28‘ ine (%8.2) radyoterapi+Jýormonoterapi uygulanmýþtýr,.
SONUÇ: Uzat metastaz görülme sýklýðý cerrahi+radyoterapi+kemoterapi grubunda en az tespit edilmiþtir. Kombine tedavi metodu uygulanan hastalarda genel saðkalým % 70 olarak bulunmuþtur.